Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.
Ontology highlight
ABSTRACT: Selective estrogen receptor modulators (SERMs), such as tamoxifen (TAM), have been used extensively for the treatment and prevention of breast cancer and other pathologies associated with aberrant estrogen receptor (ER) signaling. These compounds exhibit cell-selective agonist/antagonist activities as a consequence of their ability to induce different conformational changes in ER, thereby enabling it to recruit functionally distinct transcriptional coregulators. However, the observation that SERMs can also regulate aspects of calcium signaling and apoptosis in an ER-independent manner in some systems suggests that some of the activity of drugs within this class may also arise as a consequence of their ability to interact with targets other than ER. In this study, we demonstrate that 4-hydr
SUBMITTER: DuSell CD
PROVIDER: S-EPMC2802893 | biostudies-literature | 2010 Jan
REPOSITORIES: biostudies-literature
ACCESS DATA